P4197Evolution of vasomotor function and myocardial perfusion during three years follow-up after randomization between bioresorbable vascular scaffold and metal drug eluting stent: the VANISH trial. (28th August 2018) - Stuijfzand, W; Schumacher, S; Driessen, R; Lammertsma, A; Van Rossum, A C; Van De Ven, P; Nap, A C; Appelman, J; Lemkes, J; Van Leeuwen, M; Van Royen, N; Raijmakers, P; et al.